Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Pyridoxal phosphate hydrate 1件: Pyridoxal phosphate0件: --1件: 13
2 Phenylalanine 1件: Phenylalanine1件: Phenylalanine; --2件: 75, 240
3 Phenol -0件: ---
4 Proline 1件: Proline1件: Proline; --2件: 94, 97
5 Progesterone 1件: Progesterone1件: Progesterone; 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76
6 Propylene glycol 1件: Propylene glycol1件: Propylene glycol; --2件: 28, 51
7 Piroxicam -0件: ---
8 Pregnenolone -0件: ---
9 Pyrazinamide -0件: ---
10 Phytonadione 1件: Phylloquinone4件: Phylloquinone; Phytomenadione; Vitamin K; Vitamin K1; --6件: 13, 46, 96, 97, 288, 299
11 Parachlorophenol -0件: ---
12 Phloroglucinol -0件: ---
13 Pentostatin -0件: ---
14 Protirelin 1件: Protirelin1件: Thyrotropin releasing hormone; 1件: TRHR 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 80
15 Phenylethyl alcohol -0件: ---
16 Physostigmine -0件: ---
17 Piperacillin sodium 1件: Piperacillin1件: PIPERACILLIN; --1件: 299
18 Pipobroman -0件: ---
19 Plicamycin -0件: ---
20 Pralidoxime chloride -0件: ---
21 Prazepam -0件: ---
22 Praziquantel -0件: ---
23 Prednisolone 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
24 Prednisone 1件: Prednisone3件: Prednisona; PREDNISONE; RAYOS; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬48件: 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
25 Primidone -0件: ---
26 Probenecid 1件: Probenecid1件: Probenecid; --1件: 25
27 Probucol 1件: Probucol1件: Probucol; --1件: 66
28 Procainamide hydrochloride -0件: ---
29 Procarbazine hydrochloride 1件: Procarbazine1件: Procarbazine; --1件: 65
30 Prochlorperazine maleate -0件: ---
31 Promethazine hydrochloride 1件: Promethazine1件: Promethazine; 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 96
32 Propantheline bromide 1件: Propantheline2件: Propantheline; Propantheline Bromide; 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 26
33 Propoxyphene hydrochloride -0件: ---
34 Propranolol hydrochloride 1件: Propranolol3件: Propanolol; Propranolol; Propranolol Hydrochloride; 3件: ADRB1,
ADRB2,
ADRB3 💬
12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 158, 167, 215, 227, 278, 296
35 Protriptyline hydrochloride -0件: ---
36 Pseudoephedrine hydrochloride 1件: Pseudoephedrine1件: Pseudoephedrine; 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
37 Pyridostigmine bromide 1件: Pyridostigmine3件: Mestinon; Pyridostigmine; PYRIDOSTIGMINE BROMIDE; 1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 3, 6, 11, 256
38 Pyrimethamine 1件: Pyrimethamine2件: Daraprim; PYRIMETHAMINE; --11件: 2, 4, 6, 13, 19, 46, 51, 65, 96, 97, 265
39 Paclitaxel 1件: Paclitaxel1件: Paclitaxel; 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬
10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 46, 85
40 Prochlorperazine -0件: ---
41 Promethazine 1件: Promethazine1件: Promethazine; 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 96
42 Paramethadione -0件: ---
43 Penicillamine 1件: Penicillamine2件: D-penicillamine; PENICILLAMINE; --2件: 51, 171
44 Penicillin V potassium 1件: Phenoxymethylpenicillin0件: --3件: 13, 97, 215
45 Pentazocine -0件: ---
46 Pentobarbital -0件: ---
47 Pentobarbital sodium -0件: ---
48 Pentoxifylline 1件: Pentoxifylline1件: Pentoxifylline; --10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298
49 Pergolide mesylate 1件: Pergolide1件: PERGOLIDE; 2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
50 Perphenazine -0件: ---
51 Phenacemide -0件: ---
52 Phenelzine sulfate 1件: Phenelzine1件: Nardil; 2件: MAOA,
MAOB 💬
14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
53 Phenobarbital -0件: ---
54 Phenoxybenzamine hydrochloride -0件: ---
55 Phensuximide -0件: ---
56 Phentolamine mesylate -0件: ---
57 Phenylbutazone -0件: ---
58 Phenylephrine hydrochloride 1件: Phenylephrine1件: Phenylephrine; 3件: ADRA1A,
ADRA1B,
ADRA1D 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 22
59 Phenytoin 1件: Phenytoin1件: Phenytoin; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13
60 Pindolol -0件: ---
61 Pilocarpine 1件: Pilocarpine2件: Pilocarpine; Pilocarpine Hydrochloride; 2件: CHRM2,
CHRM3 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
62 Propofol 1件: Propofol2件: Propofol; Propofol Injection; 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬10件: 6, 21, 22, 34, 46, 70, 75, 84, 98, 296
63 Prilocaine -0件: ---
64 Pramipexole dihydrochloride 1件: Pramipexole7件: Mirapex; Mirapex ER; Mirapexin; Pramipexol; Pramipexole; PRAMIPEXOLE DIHYDROCHLORIDE; SIFROL; 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 20
65 Pimozide 1件: Pimozide1件: Pimozide; 2件: ADRA2A,
DRD2 💬
9件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2
66 Propylthiouracil -0件: ---
67 Phenacetin -0件: ---
68 Prazosin hydrochloride -0件: ---
69 Perindopril erbumine 1件: Perindopril2件: Coversyl; Perindopril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222
70 Propafenone hydrochloride -0件: ---
71 Polythiazide -0件: ---
72 Paraldehyde -0件: ---
73 Procaine hydrochloride -0件: ---
74 Pemoline -0件: ---
75 Procyclidine hydrochloride -0件: ---
76 Promazine hydrochloride -0件: ---
77 Piperazine 1件: Piperazine1件: Piperazine; --2件: 58, 272
78 Pentamidine isethionate 1件: Pentamidine2件: Pentamidina; Pentamidine; --2件: 61, 65
79 Povidone-iodine -0件: ---
80 Pravastatin sodium 1件: Pravastatin2件: Pravastatin; Pravastatin sodium; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333
81 Paricalcitol 1件: Paricalcitol1件: Paricalcitol; 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬4件: 19, 66, 218, 238
82 Pamidronate disodium 1件: Pamidronic acid1件: Pamidronate; 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 270, 271, 274
83 Pioglitazone hydrochloride 1件: Pioglitazone1件: PIOGLITAZONE; 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
84 Prednisolone acetate 2件: Prednisolone,
Prednisolone acetate
4件: Prednisolona; Prednisolone; PREDNISOLONE ACETATE; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬44件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 222, 269, 271, 296, 299, 300, 307
85 Prednisolone sodium phosphate 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
86 Prednisolone tebutate 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
87 Potassium iodide -0件: ---
88 Penicillin G potassium 1件: Benzylpenicillin0件: --1件: 46
89 Polymyxin B sulfate -0件: ---
90 Polysorbate 80 -0件: ---
91 Pemirolast potassium 1件: Pemirolast1件: PEMIROLAST; --1件: 113
92 Pyrrolnitrin -0件: ---
93 Pirenoxine -0件: ---
94 Profenamine hydrochloride -0件: ---
95 Pimobendan -0件: ---
96 Prulifloxacin -0件: ---
97 Pazufloxacin -0件: ---
98 Potassium acetate -0件: ---
99 Potassium hydroxide -0件: ---
100 Prothionamide -0件: ---
101 Phenolsulfonphthalein -0件: ---
102 Phenylpropanolamine hydrochloride -0件: ---
103 Paramethasone acetate -0件: ---
104 Pantethine 1件: Pantethine1件: Pantethine; --1件: 120
105 Prednisolone sodium succinate 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
106 Promethazine teoclate 1件: Promethazine1件: Promethazine; 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 96
107 Prilocaine hydrochloride -0件: ---
108 Pirenzepine hydrochloride -0件: ---
109 Potassium gluconate -0件: ---
110 Proscillaridin -0件: ---
111 Piperazine phosphate 1件: Piperazine1件: Piperazine; --2件: 58, 272
112 Phenolsulfonic acid -0件: ---
113 Propyl parahydroxybenzoate -0件: ---
114 Piromidic acid -0件: ---
115 Propericiazine -0件: ---
116 Potassium bitartrate -0件: ---
117 Pralidoxime iodide -0件: ---
118 Pranoprofen -0件: ---
119 Pirfenidone 1件: Pirfenidone2件: Esbriet; Pirfenidone; 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬
84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
120 Potassium guaiacolsulfonate -0件: ---
121 Polaprezinc 1件: Polaprezinc1件: Polaprezinc; --2件: 96, 97
122 Propentofylline -0件: ---
123 Pentagastrin -0件: ---
124 Piretanide -0件: ---
125 Pentaerythritol tetranitrate -0件: ---
126 Potassium sulfate -0件: ---
127 Perflutren 1件: Perflutren1件: Optison; --1件: 96
128 Propyliodone -0件: ---
129 Proxyphylline -0件: ---
130 Proglumide -0件: ---
131 Phenprobamate -0件: ---
132 Pentamycin -0件: ---
133 Pentetreotide 1件: Pentetreotide1件: Pentetreotide; --1件: 75
134 Pelubiprofen 1件: Pelubiprofen1件: Pelubiprofen; --1件: 46
135 Pirarubicin -0件: ---
136 Piracetam -0件: ---
137 Polidocanol 1件: Polidocanol1件: Polidocanol; --1件: 279
138 Prednisolone farnesylate 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
139 Prochlorperazine mesilate -0件: ---
140 Perphenazine maleate -0件: ---
141 Potassium carbonate 1件: Potassium carbonate0件: --3件: 6, 96, 291
142 Potassium nitrate -0件: ---
143 Potassium permanganate -0件: ---
144 Potassium chloride -0件: ---
145 Potassium bicarbonate -0件: ---
146 Phenytoin sodium 1件: Phenytoin1件: Phenytoin; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13
147 Pentazocine lactate -0件: ---
148 Penciclovir sodium 1件: Penciclovir0件: --1件: 13
149 Primaquine phosphate -0件: ---
150 Piperazine citrate 1件: Piperazine1件: Piperazine; --2件: 58, 272
151 Piperazine adipate 1件: Piperazine1件: Piperazine; --2件: 58, 272
152 Prednisolone hemisuccinate 1件: Prednisolone3件: Prednisolona; Prednisolone; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
153 Penicillin G benzathine 1件: Benzylpenicillin0件: --1件: 46
154 Pyrithioxine -0件: ---
155 Pyridoxine hydrochloride 1件: Pyridoxine2件: Pyridoxine; Vitamin B6; --5件: 6, 93, 145, 206, 320
156 Pilocarpine hydrochloride 1件: Pilocarpine2件: Pilocarpine; Pilocarpine Hydrochloride; 2件: CHRM2,
CHRM3 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
157 Papaverine hydrochloride -0件: ---
158 Protamine sulfate -0件: ---
159 Pentazocine hydrochloride -0件: ---
160 Piperacillin 1件: Piperacillin1件: PIPERACILLIN; --1件: 299
161 Pentobarbital calcium -0件: ---
162 Paroxetine hydrochloride hemihydrate 1件: Paroxetine1件: Paroxetine; 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85
163 Povidone -0件: ---
164 Pefloxacin -0件: ---
165 Pefloxacin mesylate -0件: ---
166 Propionic acid 1件: Propanoic acid1件: Propanoic acid; --2件: 6, 271
167 Pectin 1件: Pectin1件: Pectin; --1件: 96
168 Polyvinyl alcohol -0件: ---
169 Propiomazine -0件: ---
170 Paroxetine 1件: Paroxetine1件: Paroxetine; 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85
171 Propyl gallate -0件: ---
172 Prenylamine -0件: ---
173 Physostigmine salicylate -0件: ---
174 Phthalylsulfathiazole -0件: ---
175 Proguanil hydrochloride -0件: ---
176 Phenoxymethylpenicillin benzathine 1件: Phenoxymethylpenicillin0件: --3件: 13, 97, 215
177 Posaconazole 1件: Posaconazole2件: Noxafil; Posaconazole; --4件: 60, 65, 96, 299
178 Pantoprazole sodium 1件: Pantoprazole1件: Pantoprazole; 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65
179 Phenothiazine 1件: Phenothiazine1件: Phenothiazine; --1件: 127
180 Prochlorperazine edisylate -0件: ---
181 Phenoperidine -0件: ---
182 Pagoclone -0件: ---
183 Pipamperone -0件: ---
184 Penfluridol -0件: ---
185 Pregabalin 1件: Pregabalin2件: Lyrica; Pregabalin; 4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬
7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298
186 Palivizumab -0件: ---
187 Peginterferon alfa-2a -0件: ---
188 Peginterferon alfa-2b -0件: ---
189 Promethazine methylenedisalicylate 1件: Promethazine1件: Promethazine; 1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 96
190 Prednisolone valerate acetate 1件: Prednisolone3件: Prednisolona; PREDNISOLONE; Prednisolonum; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬43件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
191 Peanut oil -0件: ---
192 Porfimer sodium -0件: ---
193 Polyethylene glycol 3350 1件: Polyethylene glycol4件: Macrogol; Macrogol 4000; Polyethylene glycol; Polyethylene Glycol 3350; --14件: 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 235, 240, 276, 299
194 Peracetic acid -0件: ---
195 Parecoxib 1件: Parecoxib1件: Parecoxib; 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271
196 Panthenol -0件: ---
197 Perindopril 1件: Perindopril2件: Coversyl; Perindopril; 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222
198 Prinomastat -0件: ---
199 Pemetrexed disodium -0件: ---
200 Peramivir -0件: ---
201 Perphenazine fendizoate -0件: ---
202 Pine tar -0件: ---
203 Potassium L-aspartate -0件: ---
204 Perphenazine hydrochloride -0件: ---
205 Pirenzepine hydrochloride hydrate -0件: ---
206 Petrolatum 1件: Petrolatum1件: Petrolatum; --3件: 35, 158, 162
207 Paclitaxel poliglumex 1件: Paclitaxel1件: Paclitaxel; 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬
10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 46, 85
208 Padimate A -0件: ---
209 Padimate O -0件: ---
210 Palifermin 1件: Palifermin2件: Kepivance; Palifermin; 1件: FGFR2 💬13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬5件: 13, 36, 38, 39, 65
211 Paliperidone -0件: ---
212 Palmitic acid 1件: Palmitic Acid1件: Palmitate; --1件: 63
213 Pancrelipase 1件: Pancrelipase2件: Pancreatin; Pancrelipase; --2件: 298, 299
214 Panitumumab -0件: ---
215 Pantoprazole 1件: Pantoprazole1件: PANTOPRAZOLE; 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65
216 Papain -0件: ---
217 Parathyroid hormone 1件: Parathyroid hormone5件: Natpar; Natpara; Parathyroid hormone; PREOTACT; RhPTH; 2件: PTH1R,
PTH2R 💬
3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬4件: 65, 70, 235, 326
218 Paroxetine hydrochloride 1件: Paroxetine1件: Paroxetine; 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85
219 Paroxetine mesylate 1件: Paroxetine1件: Paroxetine; 1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85
220 Pascolizumab -0件: ---
221 Pegademase bovine 1件: Pegademase1件: Adagen; --1件: 65
222 Pegamotecan -0件: ---
223 Pegaspargase -0件: ---
224 Pegsunercept 1件: Pegsunercept2件: Pegsunercept; STNF-R1; 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
225 Pegvisomant 1件: Pegvisomant1件: Pegvisomant; 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
226 Peldesine -0件: ---
227 Pelitinib -0件: ---
228 Pelitrexol -0件: ---
229 Penamecillin -0件: ---
230 Penciclovir 1件: Penciclovir0件: --1件: 13
231 Penicillin V 1件: Phenoxymethylpenicillin0件: --3件: 13, 97, 215
232 Pentetic acid 1件: Pentetic acid1件: DTPA; --2件: 28, 299
233 Pentosan polysulfate sodium 1件: Pentosan polysulfate1件: Pentosan polysulfate; --3件: 19, 26, 226
234 Peppermint oil 1件: Peppermint oil1件: Peppermint oil; --1件: 226
235 Perflenapent -0件: ---
236 Perflexane -0件: ---
237 Perflubron -0件: ---
238 Perflubutane 1件: Perflubutane1件: Perflubutane; --2件: 298, 300
239 Perfosfamide -0件: ---
240 Perhexiline maleate 1件: Perhexiline1件: Perhexiline; 8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬
47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 58, 272
241 Permethrin -0件: ---
242 Pertuzumab -0件: ---
243 Perzinfotel -0件: ---
244 Phenolphthalein -0件: ---
245 Phenprocoumon -0件: ---
246 Phentermine 1件: Phentermine1件: Phentermine; 5件: MAOA,
MAOB,
SLC6A2,
SLC6A3,
SLC6A4 💬
16件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬1件: 97
247 Phentermine hydrochloride 1件: Phentermine1件: Phentermine; 5件: MAOA,
MAOB,
SLC6A2,
SLC6A3,
SLC6A4 💬
16件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Serotonergic synapse, Synaptic vesicle cycle, Tryptophan metabolism, Tyrosine metabolism 💬1件: 97
248 Phenyl aminosalicylate -0件: ---
249 Phenylmercuric nitrate -0件: ---
250 Phenylpropanolamine polistirex -0件: ---
251 Phosphoric acid -0件: ---
252 Phthalofyne -0件: ---
253 Piclamilast -0件: ---
254 Pilocarpine nitrate 1件: Pilocarpine2件: Pilocarpine; Pilocarpine Hydrochloride; 2件: CHRM2,
CHRM3 💬
13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 53, 299
255 Pimecrolimus 1件: Pimecrolimus1件: Pimecrolimus; 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 160
256 Pinacidil -0件: ---
257 Pipazethate -0件: ---
258 Piperazine edetate calcium 1件: Piperazine1件: Piperazine; --2件: 58, 272
259 Piprozolin -0件: ---
260 Pirnabine -0件: ---
261 Piroctone -0件: ---
262 Pirodavir -0件: ---
263 Piroxicam betadex -0件: ---
264 Piroxicam cinnamate -0件: ---
265 Piroxicam olamine -0件: ---
266 Pirprofen -0件: ---
267 Pixantrone 1件: Pixantrone1件: Pixantrone; 2件: TOP2A,
TOP2B 💬
1件: Platinum drug resistance 💬2件: 11, 13
268 Pizotyline -0件: ---
269 Plantago seed 1件: Plantago seed2件: Psyllium; Psyllium husk; --3件: 6, 28, 97
270 Pleconaril 1件: Pleconaril1件: PLECONARIL; --1件: 2
271 Podofilox -0件: ---
272 Polifeprosan 20 -0件: ---
273 Poliglusam -0件: ---
274 Poloxalene -0件: ---
275 Polydextrose -0件: ---
276 Polydioxanone -0件: ---
277 Polysorbate 20 -0件: ---
278 Polysorbate 60 -0件: ---
279 Porfiromycin -0件: ---
280 Pramipexole 1件: Pramipexole7件: Mirapex; Mirapex ER; Mirapexin; Pramipexol; PRAMIPEXOLE; PRAMIPEXOLE DIHYDROCHLORIDE; SIFROL; 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 20
281 Potassium citrate -0件: ---
282 Potassium guaiacolsulfonate -0件: ---
283 Potassium metabisulfite -0件: ---
284 Practolol -0件: ---
285 Pradefovir mesylate -0件: ---
286 Pralatrexate -0件: ---
287 Pralidoxime mesylate -0件: ---
288 Pramlintide -0件: ---
289 Pramlintide acetate -0件: ---
290 Prednicarbate -0件: ---
291 Prednimustine -0件: ---
292 Progabide -0件: ---
293 Propanidid -0件: ---
294 Propatyl nitrate -0件: ---
295 Propiolactone -0件: ---
296 Propylhexedrine -0件: ---
297 Proquazone -0件: ---
298 Prostalene -0件: ---
299 Protein hydrolysate -0件: ---
300 Proxazole -0件: ---
301 Pseudoephedrine polistirex 1件: Pseudoephedrine1件: Pseudoephedrine; 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
302 Pseudoephedrine sulfate 1件: Pseudoephedrine1件: Pseudoephedrine; 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
303 Pumice -0件: ---
304 Puromycin -0件: ---
305 Pyrethrum extract -0件: ---
306 Peretinoin -0件: ---
307 Pentastarch -0件: ---
308 Polycarbophil -0件: ---
309 Podophyllum resin -0件: ---
310 Polyoxyethylene (160) polyoxypropylene (30) glycol -0件: ---
311 Pemetrexed sodium hydrate -0件: ---
312 Pertussis vaccine 1件: Pertussis vaccine1件: Pertussis vaccine; --2件: 13, 46
313 Pramiconazole -0件: ---
314 Prinaberel -0件: ---
315 Pruvanserin -0件: ---
316 Pegfilgrastim 1件: Pegfilgrastim1件: Pegfilgrastim; 1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 60
317 Picotamide -0件: ---
318 Pentifylline -0件: ---
319 Palonosetron -0件: ---
320 Propamidine -0件: ---
321 Policresulen -0件: ---
322 Phenylmercuric borate -0件: ---
323 Protiofate -0件: ---
324 Promestriene -0件: ---
325 Prednylidene -0件: ---
326 Potassium perchlorate -0件: ---
327 Penimepicycline -0件: ---
328 Pidotimod -0件: ---
329 Pamidronic acid 1件: Pamidronic acid1件: Pamidronate; 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 270, 271, 274
330 Piritramide -0件: ---
331 Propacetamol -0件: ---
332 Phenglutarimide -0件: ---
333 Piribedil 1件: Piribedil1件: Piribedil; 2件: DRD2,
DRD3 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
334 Prothipendyl -0件: ---
335 Pinazepam -0件: ---
336 Proxibarbal -0件: ---
337 Pyrithyldione -0件: ---
338 Pivagabine -0件: ---
339 Pirisudanol -0件: ---
340 Phanquinone -0件: ---
341 Pholcodine -0件: ---
342 Prenoxdiazine -0件: ---
343 Pyrrobutamine -0件: ---
344 Pimethixene -0件: ---
345 Pentetrazol -0件: ---
346 Pantothenic acid -0件: ---
347 Picloxydine -0件: ---
348 Papaverine -0件: ---
349 Propenidazole -0件: ---
350 Polyestradiol phosphate -0件: ---
351 Paramethasone -0件: ---
352 Pargeverine -0件: ---
353 Paromomycin -0件: ---
354 Pemetrexed -0件: ---
355 Pemirolast 1件: Pemirolast1件: PEMIROLAST; --1件: 113
356 Penbutolol -0件: ---
357 Palmidrol 1件: Palmidrol1件: Palmitoylethanolamide; --1件: 2
358 Pentamidine 1件: Pentamidine2件: Pentamidina; Pentamidine; --2件: 61, 65
359 Pentoxyverine -0件: ---
360 Pergolide 1件: Pergolide1件: PERGOLIDE; 2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
361 Perhexiline 1件: Perhexiline1件: Perhexiline; 8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬
47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 58, 272
362 Perphenazine enantate -0件: ---
363 Pethidine 1件: Meperidine1件: Pethidine; 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
364 Phenazopyridine -0件: ---
365 Phendimetrazine -0件: ---
366 Phenelzine 1件: Phenelzine1件: Nardil; 2件: MAOA,
MAOB 💬
14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
367 Pheneticillin -0件: ---
368 Phenformin -0件: ---
369 Phenindamine -0件: ---
370 Phenindione 1件: Phenindione0件: 1件: VKORC1 💬3件: Biosynthesis of cofactors, Metabolic pathways, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 65
371 Pheniramine -0件: ---
372 Phenothrin -0件: ---
373 Phenoxybenzamine -0件: ---
374 Phenoxyethanol -0件: ---
375 Phentolamine -0件: ---
376 Phenylephrine 1件: Phenylephrine1件: Phenylephrine; 3件: ADRA1A,
ADRA1B,
ADRA1D 💬
7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 22
377 Phenylpropanolamine -0件: ---
378 Phosmet -0件: ---
379 Pilsicainide -0件: ---
380 Pioglitazone 1件: Pioglitazone1件: Pioglitazone; 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
381 Pipemidic acid -0件: ---
382 Piperacillin 1件: Piperacillin1件: PIPERACILLIN; --1件: 299
383 Piperidolate -0件: ---
384 Piperonyl butoxide -0件: ---
385 Pipethanate -0件: ---
386 Pipotiazine -0件: ---
387 Pirbuterol -0件: ---
388 Pirenzepine -0件: ---
389 Pirlimycin -0件: ---
390 Pirlindole -0件: ---
391 Pivampicillin -0件: ---
392 Polihexanide -0件: ---
393 Polygeline -0件: ---
394 Polymyxin B -0件: ---
395 Poractant alfa 1件: Poractant alfa1件: Curosurf; --1件: 211
396 Potassium 1件: Potassium1件: Potassium; --12件: 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235
397 Pramiracetam -0件: ---
398 Pramocaine -0件: ---
399 Pranlukast -0件: ---
400 Prasterone 1件: Prasterone3件: Dehydroepiandrosterone; DHEA; Prasterone; 3件: AR,
ESR1,
ESR2 💬
12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬6件: 49, 53, 83, 86, 96, 113
401 Pravastatin 1件: Pravastatin2件: Pravastatin; Pravastatin sodium; 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333
402 Prazosin -0件: ---
403 Prednisone acetate 1件: Prednisone acetate2件: Cortancyl; Prednisone acetate; 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 35, 40, 41, 46, 49, 162, 224
404 Pridinol -0件: ---
405 Pridinol hydrochloride -0件: ---
406 Primaquine -0件: ---
407 Procainamide -0件: ---
408 Procaine -0件: ---
409 Procarbazine 1件: Procarbazine1件: Procarbazine; --1件: 65
410 Procaterol -0件: ---
411 Procyclidine -0件: ---
412 Profenamine -0件: ---
413 Proglumetacin -0件: ---
414 Proguanil -0件: ---
415 Promazine -0件: ---
416 Promegestone -0件: ---
417 Propafenone -0件: ---
418 Propicillin -0件: ---
419 Propiverine 1件: Propiverine1件: Propiverine; 9件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
43件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Regulation of actin cytoskeleton, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
420 Propranolol 1件: Propranolol3件: Propanolol; Propranolol; Propranolol Hydrochloride; 3件: ADRB1,
ADRB2,
ADRB3 💬
12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 158, 167, 215, 227, 278, 296
421 Protamine hydrochloride -0件: ---
422 Protriptyline -0件: ---
423 Proxymetacaine -0件: ---
424 Pseudoephedrine 1件: Pseudoephedrine1件: Pseudoephedrine; 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
425 Pyrantel -0件: ---
426 Pargyline -0件: ---
427 Pyridoxine 1件: Pyridoxine2件: PYRIDOXINE; Vitamin B6; --5件: 6, 93, 145, 206, 320
428 Perampanel 1件: Perampanel2件: Fycompa; Perampanel; 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬
16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 6, 144
429 Picoplatin -0件: ---
430 Plerixafor 1件: Plerixafor2件: Mozobil; PLERIXAFOR; 1件: CXCR4 💬12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬6件: 19, 20, 51, 65, 285, 299
431 Pomalidomide 1件: Pomalidomide3件: Imnovid; Pomalidomida; Pomalidomide; 2件: IL6,
TNF 💬
80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬6件: 28, 34, 51, 85, 227, 331
432 Pralnacasan -0件: ---
433 Prucalopride 1件: Prucalopride2件: Prucalopride; Resolor; 1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬3件: 13, 51, 96
434 Pepper -0件: ---
435 Pegloticase -0件: ---
436 Palifosfamide -0件: ---
437 Palovarotene 1件: Palovarotene1件: PALOVAROTENE; 1件: RARG 💬-1件: 272
438 Pozanicline -0件: ---
439 Pardoprunox 1件: Pardoprunox1件: Pardoprunox; 3件: DRD2,
DRD3,
HTR1A 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6
440 Plinabulin -0件: ---
441 Preladenant 1件: Preladenant1件: Preladenant; 1件: ADORA2A 💬7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬1件: 6
442 Pegdinetanib -0件: ---
443 Peginesatide 1件: Peginesatide2件: Hematide; Peginesatide; 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
444 Plecanatide -0件: ---
445 Ponatinib -0件: ---
446 Ponezumab -0件: ---
447 Pridopidine 1件: Pridopidine1件: Pridopidine; 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 2, 6, 8
448 Pexacerfont -0件: ---
449 Pexelizumab -0件: ---
450 Pegadricase -0件: ---
451 Peginterferon lambda-1a -0件: ---
452 Pasireotide 1件: Pasireotide3件: Pasireotida; PASIREOTIDE; SIGNIFOR; 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 74, 75
453 Patiromer -0件: ---
454 Plazomicin -0件: ---
455 Pateclizumab 1件: Pateclizumab1件: MLTA3698A; 1件: LTA 💬7件: Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
456 Pictilisib -0件: ---
457 Panobinostat -0件: ---
458 Placulumab -0件: ---
459 Patidegib -0件: ---
460 Palbociclib -0件: ---
461 Pidilizumab -0件: ---
462 Pevonedistat -0件: ---
463 Pimasertib -0件: ---
464 Peginterferon beta-1a 1件: Peginterferon beta-1a2件: PEGINTERFERON BETA-1A; Plegridy; 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
465 Pegnivacogin -0件: ---
466 Pexastimogene devacirepvec -0件: ---
467 Phenibut -0件: ---
468 Paraoxon -0件: ---
469 Pefcalcitol -0件: ---
470 Pembrolizumab 1件: Pembrolizumab1件: Pembrolizumab; 1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 25, 285
471 Paritaprevir -0件: ---
472 Peficitinib 1件: Peficitinib1件: Peficitinib; 3件: JAK1,
JAK2,
JAK3 💬
37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46
473 Polmacoxib -0件: ---
474 Pradigastat -0件: ---
475 Pemafibrate 1件: Pemafibrate1件: Pemafibrate; 1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93
476 Pretomanid -0件: ---
477 Pitolisant 1件: Pitolisant1件: Pitolisant; 1件: HRH3 💬1件: Neuroactive ligand-receptor interaction 💬3件: 6, 113, 193
478 Polatuzumab vedotin -0件: ---
479 Panax notoginseng root -0件: ---
480 Plevitrexed -0件: ---
481 Pibrentasvir -0件: ---
482 Pomaglumetad methionil -0件: ---
483 Pamrevlumab 1件: Pamrevlumab1件: PAMREVLUMAB; 1件: CCN2 💬2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113
484 Pegapamodutide -0件: ---
485 Piclidenoson 1件: Piclidenoson1件: Piclidenoson; 1件: ADORA3 💬3件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
486 Plozalizumab -0件: ---
487 Padeliporfin -0件: ---
488 Pegteograstim -0件: ---
489 Plitidepsin -0件: ---
490 Pegvaliase 1件: Pegvaliase3件: Palynziq; PEGVALIASE; RAvPAL-PEG; 1件: PAH 💬5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240
491 Patisiran -0件: ---
492 Pegilodecakin -0件: ---
493 Pegvorhyaluronidase alfa -0件: ---
494 Prexasertib -0件: ---
495 Ponesimod 1件: Ponesimod1件: PONESIMOD; 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
496 Presatovir -0件: ---
497 Pexidartinib 1件: Pexidartinib1件: Turalio; 3件: CSF1R,
FLT3,
KIT 💬
15件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬1件: 34
498 Praliciguat -0件: ---
499 Pimodivir -0件: ---
500 Pavinetant -0件: ---
501 Petesicatib -0件: ---
502 Pemigatinib -0件: ---
503 Prasinezumab 1件: Prasinezumab1件: Prasinezumab; 1件: SNCA 💬3件: Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬1件: 6
504 Pamiparib -0件: ---
505 Parsaclisib 1件: Parsaclisib2件: INCB050465; Parsaclisib; 1件: PIK3CD 💬106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬3件: 35, 53, 61
506 Pepinemab -0件: ---
507 Pozelimab 1件: Pozelimab1件: Pozelimab; 1件: C5 💬10件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62
508 Pegcantratinib -0件: ---
509 Pegbelfermin -0件: ---
510 Pegcetacoplan 1件: Pegcetacoplan1件: Pegcetacoplan; 1件: C3 💬17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 62, 222
511 Pegunigalsidase alfa 1件: Pegunigalsidase alfa1件: PEGUNIGALSIDASE ALFA; --1件: 19
512 Pegzilarginase -0件: ---
513 Pralsetinib -0件: ---
514 Pacritinib -0件: ---
515 Pabinafusp alfa 1件: Pabinafusp alfa1件: Pabinafusp alfa; 2件: IDS,
TFRC 💬
8件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬1件: 19
516 Padsevonil 1件: Padsevonil1件: Padsevonil; 3件: SV2A,
SV2B,
SV2C 💬
1件: ECM-receptor interaction 💬1件: 149
517 Pimivalimab -0件: ---
518 Plasminogen -0件: ---
519 Patritumab -0件: ---
520 Poziotinib -0件: ---
521 Pafolacianine -0件: ---